Related Experiment Video
Updated: Dec 21, 2025
09:36
Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
7.0K
Protein trapping leads to altered synaptic proteostasis in synucleinopathies
Patrícia I Santos1, Tiago F Outeiro1,2,3
1Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany.
The FEBS Journal
|May 14, 2020
Summary
Toxic alpha-synuclein (aSyn) aggregates in Parkinson's disease (PD) may trap normal proteins, disrupting synaptic function. Understanding these interactions is key to developing new PD therapies.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Parkinson's disease (PD) involves alpha-synuclein (aSyn) aggregation in Lewy bodies.
- aSyn normally functions at the presynaptic terminal, balancing soluble, membrane-associated, and aggregated forms.
- Pathological aSyn accumulation at synapses impairs neuronal function and connectivity.
Purpose of the Study:
- To explore the molecular mechanisms linking aSyn accumulation and synaptic dysfunction in PD.
- To investigate the hypothesis that toxic aSyn aggregates interact abnormally with other proteins.
- To understand the role of these interactions in the prodromal and clinical stages of PD.
Main Methods:
- Literature review and synthesis of current findings on aSyn behavior.
- Hypothesis-driven discussion on protein-protein interactions involving aggregated aSyn.
- Analysis of aSyn's role in synaptic pathology.
Main Results:
- Evidence suggests aSyn aggregates may trap proteins, hindering their normal cellular functions.
- These aberrant interactions are hypothesized to initiate during prodromal PD stages.
- Synaptic dysfunction is a consequence of these toxic aSyn species.
Conclusions:
- Aberrant protein interactions caused by toxic aSyn aggregates are a potential driver of synaptic dysfunction in PD.
- Identifying the nature of toxic aSyn species is crucial for therapeutic development.
- Targeting these interactions could modify disease progression in synucleinopathies.
Related Concept Videos
03:03Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K
01:37Neural Regulation
42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K
01:45Regulation of Nuclear Protein Sorting
3.1K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K
01:13The Proteasome
1.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.5K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K